Activity evaluation of some psychoactive drugs with the application of QSAR/QSPR modeling methods. [PDF]
Kawczak P, Bober L, Bączek T.
europepmc +1 more source
Are the results of open randomised controlled trials comparing antipsychotic drugs in schizophrenia biased? Exploratory meta- and subgroup analysis. [PDF]
Leucht S+6 more
europepmc +1 more source
Concomitant Administration of Psychotropic and Prostate Cancer Drugs: A Pharmacoepidemiologic Study Using Drug-Drug Interaction Databases. [PDF]
Ungureanu D+3 more
europepmc +1 more source
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics. [PDF]
Scherf-Clavel M+7 more
europepmc +1 more source
A quantum chemical approach representing a new perspective concerning agonist and antagonist drugs in the context of schizophrenia and Parkinson's disease. [PDF]
Martínez A, Ibarra IA, Vargas R.
europepmc +1 more source
Thai national guideline for nuclear medicine investigation in movement disorders: Nuclear medicine society of Thailand, the neurological society of Thailand, and Thai medical physicist society collaboration. [PDF]
Kaewchur T+14 more
europepmc +1 more source
Neuroleptanalgesia for acute abdominal pain: a systematic review. [PDF]
Miller AC+7 more
europepmc +1 more source
A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia. [PDF]
Dong S+8 more
europepmc +1 more source
Long-term neural and physiological phenotyping of a single human [PDF]
Adeyemo, Babatunde+5 more
core +1 more source